⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EYPT News
EyePoint Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
EYPT
EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)
globenewswire.com
EYPT
Form 8-K
sec.gov
EYPT
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
EYPT
EyePoint Appoints Tarek S. Hassan, M.D., as Chief Strategic Science Officer
globenewswire.com
EYPT
Form 8-K
sec.gov
EYPT
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
EYPT
EyePoint Announces Participation at Upcoming Investor Conferences
globenewswire.com
EYPT
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
EYPT
YUTIQ Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
globenewswire.com
EYPT
ANIP
ALOT